Cas:105942-43-6 1-benzylimidazo[4,5-b]pyridine manufacturer & supplier

We serve Chemical Name:1-benzylimidazo[4,5-b]pyridine CAS:105942-43-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-benzylimidazo[4,5-b]pyridine

Chemical Name:1-benzylimidazo[4,5-b]pyridine
CAS.NO:105942-43-6
Synonyms:1-benzyl-1H-imidazo[4,5-b]pyridine;1-benzyl-4-azabenzimidazole;1-(Phenylmethyl)-1H-imidazo<4,5-b>pyridine
Molecular Formula:C13H11N3
Molecular Weight:209.24700
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:402.653ºC at 760 mmHg
Density:1.185g/cm3
Index of Refraction:1.656
PSA:30.71000
Exact Mass:209.09500
LogP:2.47960

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-benzyl-1H-imidazo[4,5-b]pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-benzyl-1H-imidazo[4,5-b]pyridine Use and application,4,5-b&gt technical grade,usp/ep/jp grade.


Related News: BetterUp is appointing several behavioral scientists, engineers, account executives, marketers, and operations professionals in the region to accelerate product innovation tailored to the European market. The company’s total European headcount is expected to reach 150 in the next year, including representation in France, Benelux, and Sweden. (2R,4S,5S)-5-(benzyloxy)-1-oxohexane-2,4-diyl diacetate manufacturers These companies need cost-effective, seamless ways to move small molecule compounds from early-phase to commercial according to global quality and regulatory standards, and these expanded facilities at our Nansha site are designed to help them to do so.” (7-nitroquinolin-8-yl) 2,4-dimethoxybenzoate suppliers During an investor event last month, Walmsley laid out her blueprint for the new GSK. It features a 5% average sales growth rate in the next five years, leading to total sales of £33 billion ($46 billion) by 2031. Glucagon-like 1 peptide GIP.GLP-1-Gly-8 (synthetic human precursor) vendor & factory.